Annual Total Long Term Liabilities
$75.16 M
-$1.67 M-2.17%
December 31, 2023
Summary
- As of February 7, 2025, SLN annual total long term liabilities is $75.16 million, with the most recent change of -$1.67 million (-2.17%) on December 31, 2023.
- During the last 3 years, SLN annual total long term liabilities has risen by +$5.20 million (+7.43%).
- SLN annual total long term liabilities is now -23.18% below its all-time high of $97.85 million, reached on December 31, 2021.
Performance
SLN Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$77.56 M
+$3.96 M+5.38%
September 1, 2024
Summary
- As of February 7, 2025, SLN quarterly total long term liabilities is $77.56 million, with the most recent change of +$3.96 million (+5.38%) on September 1, 2024.
- Over the past year, SLN quarterly long term liabilities has increased by +$2.39 million (+3.18%).
- SLN quarterly long term liabilities is now -20.74% below its all-time high of $97.85 million, reached on December 31, 2021.
Performance
SLN Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
SLN Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.2% | +3.2% |
| 3 y3 years | +7.4% | +0.9% |
| 5 y5 years | +100.0% | +0.9% |
SLN Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -23.2% | at low | -20.7% | +9.1% |
| 5 y | 5-year | -23.2% | +269.5% | -20.7% | +281.3% |
| alltime | all time | -23.2% | -100.0% | -20.7% | -100.0% |
Silence Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $77.56 M(+5.4%) |
| Jun 2024 | - | $73.59 M(+3.5%) |
| Mar 2024 | - | $71.08 M(-5.4%) |
| Dec 2023 | $75.16 M(-2.2%) | $75.16 M(+2.8%) |
| Sep 2023 | - | $73.12 M(-4.8%) |
| Jun 2023 | - | $76.81 M(+3.4%) |
| Mar 2023 | - | $74.29 M(-3.3%) |
| Dec 2022 | $76.83 M(-21.5%) | $76.83 M(+7.5%) |
| Sep 2022 | - | $71.44 M(-14.1%) |
| Jun 2022 | - | $83.19 M(-5.6%) |
| Mar 2022 | - | $88.10 M(-10.0%) |
| Dec 2021 | $97.85 M(+39.9%) | $97.85 M(+25.7%) |
| Sep 2021 | - | $77.87 M(-9.7%) |
| Jun 2021 | - | $86.21 M(+23.2%) |
| Dec 2020 | $69.96 M(+243.9%) | $69.96 M(-10.1%) |
| Jun 2020 | - | $77.83 M(+282.6%) |
| Dec 2019 | $20.34 M(>+9900.0%) | - |
| Dec 2019 | - | $20.34 M(>+9900.0%) |
| Jun 2019 | - | $0.00(0.0%) |
| Dec 2018 | $0.00(0.0%) | - |
| Dec 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | - |
| Dec 2017 | - | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | - |
| Dec 2016 | - | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | - |
| Dec 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | - |
| Dec 2014 | - | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | - |
| Dec 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00 |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $0.00(0.0%) | - |
| Dec 2012 | - | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(0.0%) | - |
| Dec 2011 | - | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | - |
| Dec 2010 | - | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(0.0%) | - |
| Dec 2009 | - | $0.00(0.0%) |
| Jun 2009 | - | $0.00(0.0%) |
| Dec 2008 | $0.00(0.0%) | - |
| Dec 2008 | - | $0.00(0.0%) |
| Jun 2008 | - | $0.00(0.0%) |
| Dec 2007 | $0.00(0.0%) | - |
| Dec 2007 | - | $0.00(0.0%) |
| Jun 2007 | - | $0.00(0.0%) |
| Dec 2006 | $0.00(-100.0%) | - |
| Dec 2006 | - | $0.00(-100.0%) |
| Jun 2006 | - | $86.90 K(-64.4%) |
| Dec 2005 | $244.20 K(-75.6%) | - |
| Dec 2005 | - | $244.20 K(-42.4%) |
| Jun 2005 | - | $424.30 K(-57.6%) |
| Dec 2004 | $1.00 M(>+9900.0%) | - |
| Dec 2004 | - | $1.00 M(>+9900.0%) |
| Jun 2004 | - | $0.00(0.0%) |
| Dec 2003 | $0.00(0.0%) | - |
| Dec 2003 | - | $0.00(0.0%) |
| Jun 2003 | - | $0.00 |
| Dec 2002 | $0.00(0.0%) | - |
| Dec 2001 | $0.00(0.0%) | - |
| Dec 2000 | $0.00(0.0%) | - |
| Dec 1999 | $0.00(0.0%) | - |
| Dec 1998 | $0.00(0.0%) | - |
| Dec 1997 | $0.00(0.0%) | - |
| Dec 1996 | $0.00(0.0%) | - |
| Dec 1995 | $0.00 | - |
FAQ
- What is Silence Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Silence Therapeutics?
- What is Silence Therapeutics annual total long term liabilities year-on-year change?
- What is Silence Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Silence Therapeutics?
- What is Silence Therapeutics quarterly long term liabilities year-on-year change?
What is Silence Therapeutics annual total long term liabilities?
The current annual total long term liabilities of SLN is $75.16 M
What is the all time high annual total long term liabilities for Silence Therapeutics?
Silence Therapeutics all-time high annual total long term liabilities is $97.85 M
What is Silence Therapeutics annual total long term liabilities year-on-year change?
Over the past year, SLN annual total long term liabilities has changed by -$1.67 M (-2.17%)
What is Silence Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of SLN is $77.56 M
What is the all time high quarterly long term liabilities for Silence Therapeutics?
Silence Therapeutics all-time high quarterly total long term liabilities is $97.85 M
What is Silence Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, SLN quarterly total long term liabilities has changed by +$2.39 M (+3.18%)